Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Everlight Chemical Industrial Corporation Kuanyin II Plant
EIR
•Everlight Chemical Industrial Corporation Kuanyin II Plant•April 10, 2015

Everlight Chemical Industrial Corporation Kuanyin II Plant – FDA EIR, Apr 10, 2015

Record Details

An FDA surveillance Good Manufacturing Practice (GMP) inspection was conducted at Everlight Chemical Industrial Corporation, an active pharmaceutical ingredient (API) manufacturer in Taoyuan Hsien, Taiwan, from April 7 to April 10, 2015. The inspection, guided by compliance program 7356.002F and ICH Q7, evaluated the company's Quality, Facilities and Equipment, Production, and Laboratory systems. The firm manufactures non-sterile API products for human drug products distributed in the US market.The inspection identified significant deviations, resulting in a 12-item FDA Form 483. Key violations included systemic failures in investigating non-conforming analytical data, inadequate data evaluation for product specifications, and poor documentation practices for analytical and production operations. The firm also failed to protect electronic raw data, monitor for endotoxin, and ensure robust process control through validation. Critical quality unit oversight was lacking, with production documents not reviewed prior to product release. Furthermore, the inspection noted a failure to support product stability with adequate data and an issue with hand washing facilities. A verbal observation highlighted the company's insufficient understanding of its supply chain, particularly regarding US market distribution. Importantly, several issues from a previous 2012 inspection persisted.Everlight Chemical Industrial Corporation's management committed to addressing all observations and providing a written response within 15 business days. The FDA classified the inspection as Official Action Indicated (OAI), signifying serious non-compliance requiring further regulatory action.

Company
Everlight Chemical Industrial Corporation Kuanyin II Plant
Inspection date
April 10, 2015
Product type
drugs
Office
Office of Regulatory Affairs
People
  • Justin A. Boyd (Research Specialist II)
  • Sherry G. Bous
  • Christina Alemu-Cruickshank (Compliance Officer)
View Company Profile

ID · 7d008074-621c-4bcd-8139-8b2b700140ef

Other documents for Everlight Chemical Industrial Corporation Kuanyin II Plant
  • 483

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Everlight Chemical Industrial Corporation Kuanyin II Plant
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.